An Exploratory Open-Label Multicentre Phase I/II Trial Evaluating the Safety and Efficacy of Postnatal or Prenatal and Postnatal Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta in Infants and Fetuses: the BOOSTB4 Trial Protocol
BMJ open(2024)
Key words
Mesenchymal Stem Cells,Cell biology,Fetal medicine,Musculoskeletal disorders,Clinical trials,TRANSPLANT MEDICINE
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined